Walleye Capital LLC Takes $8.76 Million Position in Heartflow, Inc. $HTFL

Key Points

• Walleye Capital acquired 298,568 Heartflow shares worth approximately $8.76 million in the second quarter, representing a 0.35% stake. Several other major investment firms also established new positions in the company.
• Heartflow reported strong second-quarter results, with revenue rising 47.7% year over year to $64.08 million and adjusted losses of $0.07 per share, beating the $0.22 consensus estimate. Management raised its 2026 revenue guidance to $246 million–$250 million.
• The stock has climbed 35.7% and is trading near its 52-week high, while analysts raised price targets—many to $45—but continued insider selling, including transactions by the CEO, remains a potential sentiment risk.

Walleye Capital LLC bought a new stake in Heartflow, Inc. (NASDAQ:HTFL - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 298,568 shares of the company's stock, valued at approximately $8,760,000. Walleye Capital LLC owned 0.35% of Heartflow at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. acquired a new stake in Heartflow during the 3rd quarter worth $48,871,000. Legal & General Group Plc purchased a new position in shares of Heartflow during the third quarter worth about $59,000. Franklin Resources Inc. purchased a new position in shares of Heartflow during the third quarter worth about $10,829,000. UBS Group AG acquired a new stake in shares of Heartflow during the third quarter worth about $5,130,000. Finally, Sei Investments Co. purchased a new stake in shares of Heartflow in the 3rd quarter valued at about $303,000.

Insider Activity at Heartflow

In related news, insider Campbell Rogers sold 9,219 shares of Heartflow stock in a transaction on Monday, May 18th. The shares were sold at an average price of $28.34, for a total value of $261,266.46. Following the transaction, the insider directly owned 78,731 shares in the company, valued at $2,231,236.54. This trade represents a 10.48% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 22,562 shares of the business's stock in a transaction on Monday, August 10th. The shares were sold at an average price of $28.31, for a total transaction of $638,730.22. Following the completion of the transaction, the chief executive officer directly owned 436,280 shares in the company, valued at $12,351,086.80. This represents a 4.92% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 115,805 shares of company stock valued at $3,530,609 in the last 90 days. Company insiders own 7.70% of the company's stock.

Heartflow Stock Up 35.7%

Shares of HTFL stock opened at $42.08 on Friday. The stock has a market capitalization of $3.63 billion and a PE ratio of -22.99. Heartflow, Inc. has a 52-week low of $20.13 and a 52-week high of $43.00. The stock's 50-day moving average price is $29.08 and its 200 day moving average price is $27.80.

Heartflow (NASDAQ:HTFL - Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.50% and a negative net margin of 55.82%.The firm had revenue of $64.08 million during the quarter. The firm's revenue was up 47.7% on a year-over-year basis. Analysts expect that Heartflow, Inc. will post -0.82 earnings per share for the current fiscal year.

Key Headlines Impacting Heartflow

Here are the key news stories impacting Heartflow this week:

• Positive Sentiment: Heartflow reported second-quarter revenue of $64.1 million, up 47.7% year over year, while its adjusted loss of $0.07 per share beat the consensus estimate of a $0.22 loss. The results also showed improving profitability, with adjusted EBITDA losses narrowing to $6.7 million from $10.1 million a year earlier. Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
• Positive Sentiment: Management raised full-year 2026 revenue guidance to $246 million-$250 million from $228 million-$232 million, above the roughly $230 million analyst consensus, and projected non-GAAP gross margin of about 82%. HeartFlow Shares Soar Following Strong Q2 Results and Upgraded Guidance
• Positive Sentiment: Growth was supported by stronger U.S. FFRCT volume and increasing adoption of the Plaque product, suggesting Heartflow’s AI-based coronary disease platform is broadening beyond its core business.
• Positive Sentiment: Analysts raised their targets following the report: JPMorgan increased its target to $45 and Stifel raised its target to $45, with both firms maintaining bullish ratings. Wells Fargo also raised its target to $39 and retained an “overweight” rating. Analyst Price Target Updates
• Neutral Sentiment: The strong move pushed the stock near its 52-week high, potentially increasing volatility and making valuation a greater consideration for investors despite improving operating trends.
• Negative Sentiment: Insiders have reported repeated open-market sales, including a 22,562-share sale by CEO John C.M. Farquhar. The transaction was made under a pre-arranged Rule 10b5-1 plan, which reduces its significance as a discretionary bearish signal, but continued insider selling may still weigh on sentiment. Heartflow CEO Sells Shares

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Canaccord Genuity Group upped their target price on Heartflow from $37.00 to $45.00 and gave the company a "buy" rating in a research report on Friday. JPMorgan Chase & Co. boosted their price objective on Heartflow from $35.00 to $45.00 and gave the company an "overweight" rating in a research note on Friday. Freedom Capital raised Heartflow to a "strong-buy" rating in a report on Tuesday, June 30th. Benchmark restated a "buy" rating on shares of Heartflow in a research report on Friday. Finally, Stifel Nicolaus lifted their target price on shares of Heartflow from $40.00 to $45.00 and gave the company a "buy" rating in a report on Friday. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, Heartflow presently has an average rating of "Moderate Buy" and a consensus target price of $43.43.

Heartflow Company Profile

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

Want to see what other hedge funds are holding HTFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Heartflow, Inc. (NASDAQ:HTFL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source